<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p>Severe or 'complicated malaria' can arise from delay in diagnosis or inappropriate treatment of uncomplicated malaria. It mostly occurs in children under 5 years of age, pregnant women and non-immune individuals. The events causing most deaths in severe malaria are related to cerebral involvement (cerebral malaria), severe anaemia, hypoglycaemia, severe dehydration, renal failure and respiratory acidosis. The diagnosis of severe malaria is based on clinical features and confirmed with laboratory testing. Not all cases of severe malaria have high parasitaemia and initial blood film examination may be negative.</p><p>Where the diagnosis is suspected, treatment must be started without delay while awaiting confirmation.</p><p><strong>SYMPTOMS</strong></p><ul><li>Poor oral intake (e.g. breast milk in children)</li><li>Repeated profuse vomiting</li><li>Dark or 'cola-coloured' urine</li><li>Passing of very little urine</li><li>Difficulty in breathing</li><li>Generalised weakness, inability to walk or sit without assistance</li><li>Altered consciousness (change of behaviour, confusion, delirium, coma)</li><li>Repeated generalized convulsions</li></ul><p>&nbsp;</p><p><strong>SIGNS</strong></p><ul><li>Hyperpyrexia (axillary temperature &gt; 38.5°C)</li><li>Extreme pallor (severe anaemia; Hb &lt; 5 g/dl)</li><li>Marked jaundice</li><li>Circulatory collapse or shock (cold limbs, weak rapid pulse)</li><li>Tachypnoea (Rapid breathing)</li><li>Crepitations on chest examination</li><li>Sweating (due to hypoglycaemia)</li><li>Haemoglobinuria (dark or 'cola-coloured' urine)</li><li>Oliguria</li><li>Spontaneous unexplained&nbsp; heavy&nbsp;&nbsp; bleeding (disseminated intravascular coagulation)</li><li>Altered consciousness (change of behaviour, confusion, delirium, coma)</li></ul><p>&nbsp;</p><p><strong>INVESTIGATIONS</strong></p><ul><li>Rapid diagnostic test</li><li>Blood film for malaria parasites - thick and thin blood films (should be done where available)</li><li>FBC</li><li>Sickling test</li><li>Random blood glucose</li><li>BUE and creatinine</li><li>Blood grouping and cross-matching</li><li>Lumbar puncture in the convulsing or comatose patient to exclude meningitis or encephalitis</li></ul><p>&nbsp;</p><p><strong>TREATMENT</strong></p><p><strong>Treatment objectives</strong></p><ul><li>To ensure rapid clearance of parasitaemia</li><li>To provide urgent treatment for life threatening complications or conditions e.g. convulsions, hypoglycaemia, dehydration, renal impairment</li><li>To provide appropriate supportive care</li></ul><p>&nbsp;</p><p><strong>Non-pharmacological treatment</strong></p><ul><li>Place patients who are unconscious or having seizures in an appropriate position to prevent aspiration</li></ul><p><strong>Pharmacological treatment</strong></p><p>Evidence Rating: [A]</p><p><strong>A. Pre-referral treatment</strong></p><ul><li>Artesunate, IM,</li></ul><p><strong>ADULTS</strong> and <strong>CHILDREN</strong> &gt; 20 kg 2.4 mg/kg&nbsp;</p><p><strong>CHILDREN</strong> &lt; 20 kg 3 mg/kg</p><p><strong>Or</strong></p><ul><li>Artemether, IM,</li></ul><p><strong>ADULTS</strong> and <strong>CHILDREN</strong>- .2 mg/kg</p><p>&nbsp;</p><p><strong>Or</strong></p><ul><li>Quinine, IM, 10Artesunate, rectal, 10 mg/kg (preferred in children under 6 years; see Table 110)</li></ul><p><strong>Or</strong></p><ul><li>Artesunate, rectal, 10 mg/kg (preferred in children under 6 years;</li></ul><div class="table"><table><tbody><tr><td colspan="2"><strong>Table 18-10: Dosing Regimen for Quinine IM Injection in young Children</strong></td></tr><tr><td>Weight</td><td>Volume of Quinine Dihydrochloride Injection (50 mg/ml dilution)</td></tr><tr><td>&lt; 5 kg</td><td>1.0 ml</td></tr><tr><td>5.1-7.5 kg</td><td>1.5 ml</td></tr><tr><td>7.6-10.0 kg</td><td>2.0 ml</td></tr><tr><td>10.1-12.5 kg</td><td>2.5 ml</td></tr><tr><td>12.6-15.0 kg</td><td>3.0 ml</td></tr><tr><td>15.1-17.5 kg</td><td>3.5 ml - half to each thigh</td></tr></tbody></table></div><p>&nbsp;</p><div class="table"><table><tbody><tr><td><strong>Note 18-10</strong></td></tr><tr><td><p><strong>How to give Intramuscular Quinine Intramuscular Quinine in Young&nbsp;Children:</strong></p><ul><li>Weigh the&nbsp;child</li><li>Prepare a Quinine dilution of 50 mg/ml: Use a 10 ml sterile syringe and needle&nbsp;to&nbsp;drawup&nbsp;5&nbsp;mls&nbsp;of&nbsp;sterile&nbsp;water&nbsp;for&nbsp;injection&nbsp;or&nbsp;saline&nbsp;(notdextrose). Then into the same syringe draw up 300 mg (1ml) from an ampoule of Qui- nine. The syringe now contains 50 mg Quinine per&nbsp;ml.</li><li>The dosage is 10 mg (0.2 ml) per kg or body weight every 8 hours. Calculate the volume to give based on body weight. (For examples of body weights and doses in children &lt; 30 kg, sArtesunate, rectal, 10 mg/kg (preferred in children under 6&nbsp;years;110).</li><li>Administer by intramuscular injection to the thigh. If the diluted volume&nbsp;exceeds 3 ml, inject half the dose into each&nbsp;thigh.</li></ul><p><strong>Intramuscular Quinine in Adults:</strong></p><ul><li>Use&nbsp;a&nbsp;Quinine&nbsp;dilution&nbsp;of&nbsp;100&nbsp;mg/ml. To&nbsp;prepare&nbsp;this,&nbsp;draw 2&nbsp;mls&nbsp;of&nbsp;Quinine 600 mg and add 4 mls of sterile water or saline (not&nbsp;dextrose)</li><li>The dosage is 10 mg/kg body weight of Quinine given 8 hourly by deep IM injection, to a maximum dose of 600&nbsp;mg</li><li>Small adults (weighing less than 60 kg) should be weighed to calculate the correct dose. Larger adults will simply receive the maximum dose (600&nbsp;mg)</li><li>If&nbsp;the&nbsp;required&nbsp;volume is&nbsp;more&nbsp;than&nbsp;5&nbsp;ml,&nbsp;divide&nbsp;it&nbsp;into&nbsp;two&nbsp;and&nbsp;inject at separate sites</li></ul></td></tr></tbody></table></div><p>&nbsp;</p><p>&nbsp;</p><div class="table"><table><tbody><tr><td colspan="2"><strong>Table 18-10: Dosing Regimen for Quinine IM Injection in young Children</strong></td></tr><tr><td>17.6-20.0 kg</td><td>4.0 ml - half to each thigh</td></tr><tr><td>20.1-22.5 kg</td><td>4.5 ml - half to each thigh</td></tr><tr><td>22.6-25.0 kg</td><td>5.0 ml - half to each thigh</td></tr><tr><td>25.1-27.5 kg</td><td>5.5 ml - half to each thigh</td></tr><tr><td>27.6-30.0 kg</td><td>6.0 ml - half to each thigh</td></tr></tbody></table></div><p>The dosage for IM Quinine is 10 mg (0.2 ml) per kg of bodyweight every 8&nbsp;hours.</p><p>&nbsp;</p><p>&nbsp;</p><div class="table"><table><tbody><tr><td colspan="4"><strong>Table 18-11: Rectal Artesunate (Pre-Referral Treatment in Children)</strong></td></tr><tr><td>Weight</td><td>Age</td><td>Artesunate Dose</td><td>Regimen</td></tr><tr><td>5 - 8 kg</td><td>&lt; 1 yr</td><td>50</td><td>0ne 50 mg suppository</td></tr><tr><td>9 - 19 kg</td><td>1 - 1½ yrs</td><td>100</td><td>Two 50 mg suppositories</td></tr><tr><td>20 - 29 kg</td><td>1½ - 5 yrs</td><td>200</td><td>0ne 200 mg suppository</td></tr><tr><td>30 - 39 kg</td><td>6 - 13 yrs</td><td>300</td><td><p>Two 50 mg and one 200 mg</p><p>suppositories</p></td></tr><tr><td>&gt;40 kg</td><td>&gt;14 yrs</td><td>400</td><td>Two 200 mg suppositories</td></tr></tbody></table></div><p>&nbsp;</p><div class="table"><table><tbody><tr><td><strong>Note 18-11</strong></td></tr><tr><td><p><strong>Parenteral antimalarials and follow-on treatment.</strong></p><p>The current recommendation is to give parenteral antimalarials in the treatment&nbsp;of&nbsp;severe malaria&nbsp;for&nbsp;a&nbsp;minimum&nbsp;of&nbsp;24&nbsp;hours(irrespective&nbsp;of&nbsp;the patient's ability&nbsp;to&nbsp;tolerate&nbsp;oral&nbsp;medication)&nbsp;until the&nbsp;patient&nbsp;is&nbsp;able&nbsp;to&nbsp;tolerate&nbsp;oral medication as follow-on treatment. Recommended follow-on treatments include ACTs&nbsp;and Quinine + clindamycin.</p></td></tr></tbody></table></div><p>&nbsp;</p><p><strong>B. Treatment in Referral Centre</strong></p><ul><li>Artesunate, IV or IM,</li></ul><p><strong>ADULTS</strong> and CHILDREN &gt; 20 kg</p><p>2.4 mg/kg 12 hourly</p><p>Given at time 0 hour (i.e. on admission), at 12 hours and 24 hours</p><p><strong>Then</strong></p><p>2.4 mg/kg daily until patient can swallow (max. 7 days)</p><p><strong>Then</strong></p><p>A full 3-day course of recommended oral artemisinin combination</p><p>therapy (ACT) <strong>CHILDREN</strong> &lt; 20 kg</p><p>3 mg/kg 12 hourly</p><p>Given at time 0 hour (i.e. on admission), at 12 hours and 24 hours</p><p><strong>Then</strong></p><p>3.0 mg/kg daily until patient can swallow (max. 7 days)</p><p><strong>Then</strong></p><p>A full 3-day course of recommended oral ACT</p><div class="table"><table><tbody><tr><td>Note 18-12</td></tr><tr><td><p><strong>Artesunate reconstitution for parenteral injection</strong></p><p><strong>Reconstitution:</strong></p><p>Use a syringe to draw and inject the solvent (sodium bicarbonate 50mg/ml solution) into the vial of artesunate powder. Shake the vial until the powder is completely dissolved and the solution is clear.</p><p>For intravenous injection: Add either glucose 50 mg/ml (i.e. 5% Dextrose solution) or sodium chloride 9 mg/ml (i.e. 0.9% Normal saline solution) to the re- constituted artesunate solution to create a 10 mg/ml solution of artesunate. Draw required volume and give slowly by IV at about 3-4 ml/min. Add either glucose 50 mg/ml (i.e. 5% Dextrose solution) or sodium chloride 9 mg/ml (i.e. 0.9%&nbsp;Normal saline&nbsp;solution)&nbsp;to&nbsp;the&nbsp;reconstituted&nbsp;artesunate&nbsp;solution&nbsp;to&nbsp;create a&nbsp;20&nbsp;mg/ml&nbsp;solution&nbsp;of&nbsp;artesunate.&nbsp;Draw required&nbsp;volume&nbsp;and&nbsp;give&nbsp;slowly by&nbsp;IM anterior thigh. If the required volume is more than 5 ml, divide it into two and inject at separate sit. Add either glucose 50 mg/ml (i.e. 5% Dextrose solution) or sodium&nbsp;chloride&nbsp;9&nbsp;mg/ml&nbsp;(i.e.0.9%&nbsp;Normal&nbsp;saline solution)&nbsp;to&nbsp;the&nbsp;reconstituted artesunate&nbsp;solution&nbsp;to&nbsp;create&nbsp;a&nbsp;20&nbsp;mg/ml solution&nbsp;of&nbsp;artesunate.&nbsp;Draw&nbsp;required volume and give slowly by IM anterior thigh. If the required volume is more than&nbsp;5&nbsp;ml,&nbsp;divide&nbsp;it&nbsp;into&nbsp;two&nbsp;and&nbsp;inject at&nbsp;separate&nbsp;sit Add either&nbsp;glucose&nbsp;50&nbsp;mg/ ml&nbsp;(i.e.&nbsp;5%&nbsp;Dextrose&nbsp;solution)&nbsp;or&nbsp;sodium&nbsp;chloride&nbsp;9&nbsp;mg/ml&nbsp;(i.e.&nbsp;0.9%&nbsp;Normal&nbsp;saline solution) to the reconstituted artesunate solution to create a 20 mg/ml solution of artesunate. Draw required volume and give slowly by IM anterior thigh. If the required volume is more than 5 ml, divide it into two and inject at separate sites. (See Table 112).</p><p><strong>For intramuscular injection:</strong></p><p>Add either glucose 50 mg/ml (i.e. 5% Dextrose solution) or sodium chloride 9 mg/ml (i.e. 0.9% Normal saline solution) to the reconstituted artesunate solution to create a 20 mg/ml solution of artesunate. Draw required volume and give slowly&nbsp;by&nbsp;IM&nbsp;anterior&nbsp;thigh. If&nbsp;the&nbsp;required&nbsp;volume&nbsp;is&nbsp;morethan&nbsp;5&nbsp;ml, divide it into two and inject at separate site. Add either glucose 50 mg/ml (i.e. 5% Dextrose&nbsp;solution)&nbsp;or&nbsp;sodium&nbsp;chloride&nbsp;9&nbsp;mg/ml&nbsp;(i.e.0.9%&nbsp;Normal&nbsp;saline solution)&nbsp;to the reconstituted artesunate solution to create a 20 mg/ml solution of artesunate.&nbsp;Draw required&nbsp;volume&nbsp;and&nbsp;give&nbsp;slowly by&nbsp;IM&nbsp;anterior&nbsp;thigh.&nbsp;If&nbsp;the&nbsp;required volume&nbsp;is&nbsp;more&nbsp;than5&nbsp;ml,&nbsp;divide it&nbsp;into&nbsp;two&nbsp;and&nbsp;inject at&nbsp;separate&nbsp;site. Add&nbsp;either glucose 50 mg/ml (i.e. 5% Dextrose solution) or sodium chloride 9 mg/ml (i.e. 0.9%&nbsp;Normal&nbsp;saline solution)&nbsp;to&nbsp;the reconstituted&nbsp;artesunate&nbsp;solution&nbsp;to&nbsp;create a&nbsp;20&nbsp;mg/ml&nbsp;solution&nbsp;of&nbsp;artesunate.&nbsp;Draw required&nbsp;volume&nbsp;and&nbsp;give&nbsp;slowly by&nbsp;IM anterior thigh. If the required volume is more than 5 ml, divide it into two and inject at separate sites. (See Table&nbsp;112)</p><p>&nbsp;</p></td></tr></tbody></table></div><p>&nbsp;</p><div class="table"><table><tbody><tr><td colspan="7"><strong>Table 18-12: Approximate quantities for dilution</strong></td></tr><tr><td>Route</td><td colspan="2">IV Injection</td><td>&nbsp;</td><td colspan="2">IM Injection</td><td>&nbsp;</td></tr><tr><td>Strength of medicine</td><td>30 mg</td><td>60 mg</td><td>120 mg</td><td>30 mg</td><td>60 mg</td><td>120 mg</td></tr><tr><td>Sodium bicarbonate 50 mg/ml solution for reconstitution (ml)</td><td>0.5</td><td>1</td><td>2</td><td>0.5</td><td>1</td><td>2</td></tr><tr><td><p>Glucose 50 mg/ml solution for injection 0r</p><p>Sodium chloride 9 mg/ml for injection (ml)</p></td><td>2.5</td><td>5</td><td>10</td><td>1</td><td>2</td><td>4</td></tr><tr><td>Total diluent needed (ml)</td><td>3</td><td>6</td><td>12</td><td>1.5</td><td>3</td><td>6</td></tr><tr><td>Artesunate concentration (mg/ ml)</td><td>10</td><td>10</td><td>10</td><td>20</td><td>20</td><td>20</td></tr></tbody></table></div><p>&nbsp;</p><div class="table"><table><tbody><tr><td><strong>Note 18-13</strong></td></tr><tr><td><p><strong>Calculation of dose of Artesunate needed (ml):</strong></p><p><strong>Adults:</strong></p><p>For IV route:</p><p>2.4 mg x body weight (kg)</p><p>IV Artesunate solution concentration 10 mg/ml</p><p>For IM route:</p><p>2.4 mg x body weight (kg)</p><p>IM Artesunate solution concentration 20 mg/ml</p><p><strong>Children &lt; 20kg:</strong></p><p>For IV route:</p><p>3 mg x body weight (kg)</p><p>IV Artesunate solution concentration 10 mg/ml For IM route:</p><p>3 mg x body weight (kg)</p><p>IM Artesunate solution concentration 20 mg/ml</p><p><strong>Precautions:</strong></p><ul><li>Inject immediately&nbsp;after&nbsp;reconstitution&nbsp;and&nbsp;discard&nbsp;if&nbsp;not&nbsp;used within&nbsp;1&nbsp;hour</li><li>Discard if solution is not&nbsp;clear</li><li>Do&nbsp;not&nbsp;use&nbsp;in&nbsp;IV&nbsp;drip,&nbsp;Give slowly&nbsp;by&nbsp;direct IV&nbsp;injection&nbsp;at&nbsp;about&nbsp;3-4ml/min</li></ul><p>&nbsp;</p></td></tr></tbody></table></div><p>&nbsp;</p><p>&nbsp;</p><p><strong>Or</strong></p><ul><li>Artemether, IM,</li></ul><p><strong>ADULTS</strong> and CHILDREN</p><p>3.2 mg/kg stat.</p><p><strong>Then&nbsp;</strong>(8 hours later)</p><p>1.6 mg/kg</p><p><strong>Then&nbsp;</strong>(24 hours after initiation of treatment)</p><p>1.6 mg/kg once daily until patient can swallow (up to 5 days)</p><p>&nbsp;</p><p><strong>Then</strong></p><p>A full 3-day course of recommended oral artemisinin combination therapy (ACT)</p><p><strong>Or</strong></p><ul><li>Quinine, IV, (in Dextrose saline or in 5% Dextrose [5-10 ml/kg])</li></ul><p><strong>ADULTS</strong> and <strong>CHILDREN</strong></p><p>10 mg/kg (max. dose 600 mg) infused over 4-8 hours. Repeat infusion 8 hourly until patient can swallow.</p><p>&nbsp;</p><p><strong>Then</strong></p><ul><li>Quinine, oral, 10 mg/kg 8 hourly to complete 7 days of treatment</li></ul><p><strong>And</strong></p><ul><li>Clindamycin, oral, 10 mg/kg, 12 hourly for 7 days</li></ul><div class="table"><table><tbody><tr><td><strong>Note 18-14</strong></td></tr><tr><td>Clindamycin should be administered with food and copious amounts of water. Quinine, IV, should always be given by a slow infusion, never by bolus intravenous injection as this may cause severe hypotension.</td></tr></tbody></table></div><p>&nbsp;</p><p><strong>Or</strong></p><ul><li>Quinine, IM,</li></ul><p><strong>ADULTS</strong> and <strong>CHILDREN</strong></p><p>10 mg/kg (max. dose 600 mg), 8 hourly until patient can swallow</p><p><strong>Then</strong></p><ul><li>Quinine, oral, 10 mg/kg 8 hourly to complete 7 days of treatment</li></ul><p><strong>And</strong></p><ul><li>Clindamycin, oral, 10 mg/kg, 12 hourly for 7 days</li></ul><p>&nbsp;</p><p><strong>REFERRAL CRITERIA</strong></p><p>Patients diagnosed as having severe malaria or who fail to respond to the recommended antimalarial medications must be referred. Appropriate treatment as indicated above must be initiated prior to transferring the patient. If referral is not possible immediately, continue the treatment regimen as shown above for severe malaria until referral is possible.</p>
</body>
</html>
